subjects. Conclusions: Reduced platelet 5-HT concentrations in hypothyroid patients suggests a complex interaction between the 5-HT system and HPT axis activity, which could be related to the frequent occurrence of depressive symptoms in hypothyroid patients. The determination of platelet 5-HT concentrations should be considered a diagnostic tool for the evaluation of depressive symptoms in hypothyroid patients during the hormone withdrawal procedure.
Platelet Serotonin Concentration and Monoamine Oxidase Activity in Hypothyroid Patients
. Studies on the relationship between the HPT axis and 5-HT system in humans are scarce and have focused on thyroid hormone alterations in psychiatric patients. Hypothyroidism appears in 8% of the adult population [11] , and could be one of the risk factors for the development of depression [12] . Augmentation therapy with T 3 or T 4 to different antidepressants induced remission in treatment-resistant depressed patients [13] . In hypothyroid female patients, treatment with T 4 induced a significant decrease in pretreatment values of 5-HT and catecholamine precursor in cerebrospinal fluid [14] . A significant decrease in D -fenfluramine-induced cortisol response was also found in hypothyroid patients [15] , probably due to a decrease in 5-HT2A receptor sensitivity [16] . It has been hypothesized that alterations in the HPT axis in nontreated depressed subjects could be explained by both 5-HT and noradrenaline (NE) brain alterations [17] . In particular NE participates in the release of thyrotropin-releasing hormone (TRH) and TSH [18] . In hypothyroidism a deficiency of T 3 accompanied by an increase in TSH in the brain alters the noradrenergic neurotransmission by reducing ␤ -adrenergic receptors [19] . Additional studies on TSH are scarce and inconsistent in depressed patients. An excessive response of TSH to the TRH challenge test was found in 10% [20] and a decreased response in 25% of the patients [21] .
Blood platelets are thought to be a limited peripheral model for central 5-HT neurons due to similarities in the structure and function of 5-HT receptors and the 5-HT transporter, expressed both in platelets and 5-HT neurons [22] , while platelet biochemical markers (5-HT concentration, monoamine oxidase type B, MAO-B, activity) might be used as peripheral biological and/or trait markers for particular symptoms in depression [23, 24] or schizophrenia [25, 26] . Platelet 5-HT originates from the peripheral pool of 5-HT which is synthesized in the enterochromaffin cells of the gastrointestinal tract, released via the blood stream into platelets and stored in dense granules. Platelet 5-HT is involved in thrombus formation, atherogenesis and vasoconstriction on the site of endothelial injury; it also plays a growth factor role for mitogenesis of arterial smooth muscle cells, proliferation of endothelial cells, and in vascular inflammation it is associated with atherogenesis by increasing the synthesis of interleukin-6 in vascular smooth muscle cells [27] . Besides these functions, platelet 5-HT acts as a neurotransmitter for the peripheral nervous system, influences gastric and intestinal ion secretion and intestinal motility [28] , and plays an additional role as an enhancer of platelet aggregation [29] . The mitochondrial enzyme MAO exists as two isoforms, MAO-A and MAO-B, that differ in tissue distribution and substrate specificity. Platelets include only the MAO-B isoform which regulates the levels of exogenous dietary amines in peripheral tissues (phenylethylamine), but it can also oxidize dopamine, noradrenaline, adrenaline, tryptamine and tyramine, and is inhibited by deprenyl [30] . When the MAO-A enzyme is absent or inhibited, MAO-B also metabolizes 5-HT [31] . In hypothyroidism, some studies [32, 33] found no significant differences in platelet activities between hypothyroid patients and healthy subjects, while in a more recent study, a difference in the mean platelet volume, with no changes in platelet counts, was found in patients compared to healthy controls [34] .
In accordance with the relationship between the HPT axis and 5-HT system, we hypothesized that platelet biochemical markers would be altered in hypothyroid patients. The aim of this study was to determine the platelet 5-HT concentration and platelet MAO-B activity in medication-free female patients in the hypothyroid state induced by withdrawal of levothyroxine after total thyroidectomy due to papillary carcinoma, and in age-and sexmatched euthyroid healthy control subjects.
Subjects and Methods
The study included 25 female patients (mean age 49.3 8 1.2; range 24-74 years) who had undergone total thyroidectomy due to papillary carcinoma. The average time since thyroidectomy was 3.4 8 1.8 years. All patients were currently in the hypothyroid state with elevated TSH after withdrawal of replacement T 4 (levothyroxine) therapy during 4 weeks, but in good health and without postoperative complications such as hypoparathyroidism or cancer recurrence. The hypothyroid state was required to increase the sensitivity of the serum thyroglobulin test ( 1 2 g/l), and radioiodine whole-body scanning (which showed no pathological activity) to evaluate the effectiveness of surgical treatment [35] . The control group consisted of 44 healthy female euthyroid subjects (mean age 46.2 8 8.9; range 28-77 years). Control subjects with abnormal liver or thyroid function tests were excluded. Apart from the radiological and nuclear medical testing, control subjects were examined in the same manner as patients. Twelve patients and 17 healthy controls were menopausal. All subjects were nonsmokers and free of concomitant psychiatric and additional endocrine illnesses. Subjects taking antihypertensive, antiallergic, anxiolytic, antirheumatic, cholesterol-lowering, hormonal supplemental or contraceptive therapy and drugs affecting platelet 5-HT values (antidepressants) or MAO-B activity (MAO inhibitors) were excluded from the study. The study was approved by the local ethics committee and all participants gave written informed consent.
Each patient underwent a complete medical evaluation before radiological examination and blood sampling. After overnight fasting and between 8 and 10 a.m., 5 ml of blood was drawn from a cubital vein to analyze serum T 4 and TSH levels. An additional 5 ml of blood was drawn into a tube containing 1 ml acid citrate dextrose anticoagulant to determine the platelet 5-HT concentration and platelet MAO-B activity. Platelet-rich plasma was obtained by centrifugation (935 g ) for 70 s at room temperature. Platelets were sedimented by further centrifugation of plateletrich plasma at 10,000 g for 5 min. The platelet pellet was washed with saline and centrifuged again. Platelet 5-HT concentrations and platelet MAO-B activity were determined by spectrofluorimetric methods as previously described [36] using Varian Carry Eclypse spectrofluorimeter. Platelet protein was determined by the method of Lowry et al. [37] .
Serum T 4 and TSH were determined by radioimmunoassay (RIA) and time-resolved fluoroimmunoassay (Delfia) with kits from Perkin-Elmer. Intra-and inter-assay variation coefficients were 3.6% for T 4 and 3.5% for TSH. The range of normal values was 70-165 nM for T 4 and 0.4-4.2 mU/l for TSH.
The results are expressed as mean 8 standard deviations (SD). The differences between groups were evaluated by Mann-Whitney t test. The correlation between parameters was determined using Spearman's coefficient of correlation. The criterion for significance in all tests was p ! 0.05. The statistical package used was SigmaStat 3.1.
Results
As expected, TSH values were significantly (p ! 0.001) higher, and T 4 significantly (p ! 0.001) lower in hypothyroid patients compared to hormone values in healthy subjects ( table 1 ) . Platelet MAO-B activity did not differ significantly (p = 0.120) between patients and control subjects ( table 1 ) .
Platelet 5-HT concentrations differed significantly (p ! 0.001) between patients and healthy controls ( fig. 1 ) , and 5-HT values were significantly, i.e. 35%, lower in hypothyroid patients than in euthyroid control subjects.
A significant positive correlation between 5-HT levels and platelet MAO-B activity was found in control subjects (r = 0.581; p = 0.000), but not in hypothyroid patients (r = 0.372; p = 0.067). No significant correlation was observed between platelet 5-HT and T 4 levels in healthy subjects (r = 0.249; p = 0.103) or in patients (r = 0.115; p = 0.579), or between platelet 5-HT and TSH levels in healthy subjects (r = -0.276; p = 0.070) or in patients (r = 0.244; p = 0.237). There was a significant positive correlation between platelet MAO activity and T 4 levels in healthy controls (r = 0.322; p = 0.033), but not in patients (r = -0.067; p = 0.75). No significant correlation was observed between platelet MAO activity and TSH levels in healthy subjects (r = 0.004; p = 0.98) or in patients (r = 0.131; p = 0.529).
Discussion
The main finding of the present study was that subjects in a pronounced hypothyroid state induced by withdrawal of replacement T 4 therapy after thyroidectomy had significantly lower platelet 5-HT concentrations than Results are expressed as mean 8 SD. The number of subjects is given in parentheses. * p < 0.001 vs. euthyroid controls (Mann-Whitney t test). euthyroid control subjects. This is the first study showing reduced platelet 5-HT concentrations in hypothyroid patients, and these data suggest that hypothyroidism influences the peripheral, i.e. platelet 5-HT, system. A reduced platelet 5-HT concentration is associated with female gender, comorbid diagnosis, alcoholism, suicidal behavior, or antidepressant treatment. The effect of sex [23] [24] [25] [26] 38] was excluded in this study, since we recruited only female subjects. The effects of comorbid diagnosis [38] , suicidal behavior [23] [24] [25] , alcoholism [39] , or the effects of different medications [24, 36] were ruled out by the study exclusion criteria. To avoid the influence of daylight exposure on platelet 5-HT values [40] , patients and controls were sampled at the same time. Different phases of menstrual status might influence platelet 5-HT concentrations, platelet MAO-B activity and serum T 4 and TSH values. However, no significant differences in whole blood 5-HT [41] , serum T 3 and T 4 [42] levels were detected in healthy women during the follicular, ovulatory or luteal phases of the menstrual cycle. Although a positive correlation between platelet 5-HT concentration and plasma estrogen levels was found [43] , we have shown similar platelet 5-HT concentrations in healthy premenopausal and postmenopausal depressed and schizophrenic women [44] . Our results show that platelet 5-HT concentrations are reduced in hypothyroid patients, and these data might be in line with a hypothyroidism-induced reduction in central 5-HT activity, since reduced responses to both cortisol and prolactin (index of central 5-HT responsivity) to D -fenfluramine (centrally acting 5-HT-releasing agent) were found in hypothyroid patients [15] .
The decrease in platelet 5-HT concentration in the present study suggests a reduced 5-HT synthesis or increased metabolism. Preclinical data showed decreased activity of tryptophan hydroxylase, a rate-limiting enzyme involved in the biosynthesis of 5-HT, in animals with experimentally induced hypothyroidism [7] .
The reduced platelet 5-HT concentration in our study could be related to the increased metabolism of 5-HT, due to the altered activity of MAO in patients with severe hypothyroidism. However, female hypothyroid patients and control subjects had similar platelet MAO-B activity (present study), and MAO-B activity was not affected by thyroid hormones in the rat brain [45] , indicating that thyroid hormone status did not significantly alter platelet MAO-B activity. Platelet MAO-B activity might be affected by various factors such as gender, age, ethnicity, smoking, some neurodegenerative diseases, and medication [46] , and to control for these variables the present study included only medication-free Caucasian female patients with no neurodegenerative diseases who were matched for age with control subjects, and all participants were nonsmokers. Even though 5-HT is not a main substrate for MAO-B [46] , since MAO-A preferentially metabolizes 5-HT, it has been shown that MAO-B could be involved in the direct regulation of 5-HT synthesis in the rat brain [47] and platelet MAO-B activity has been proposed to be an indicator of the central 5-HT system [46] . Preclinical studies suggest that brain and thyroid MAO-A activities were slightly increased in hypothyroid rats [45] . Since we did not determine MAO-A activity in our hypothyroid patients and control subjects, and there are no literature data regarding peripheral MAO-A activity in hypothyroid patients, we can only speculate that the decreased 5-HT in patients with hypothyroidism might have been induced by an increased MAO-A activity.
We found a positive correlation between the platelet 5-HT concentration and platelet MAO-B activity and between T 4 levels and platelet MAO-B activity in control participants whose thyroid hormonal status and platelet biochemical markers were within the normal range. The lack of correlation between platelet 5-HT, MAO-B activity and T 4 levels in patients in a severe hypothyroid state suggests an altered and more complex relationship between the HPT axis and 5-HT, which might be due to the reduced T 4 and platelet 5-HT concentrations.
If the platelet 5-HT concentration might be used as a limited peripheral indicator of the central 5-HT function [22, 24, 26] , the results of the present study indicate that hypothyroid patients have a lower platelet 5-HT concentration and possibly reduced central 5-HT function. Hypothyroid patients frequently experience depressive symptoms [48] , and depressive patients [23, 24] , similarly to our hypothyroid patients, have a decreased platelet 5-HT concentration. In addition, the addition of T 3 or T 4 to antidepressant therapy improved the clinical state in treatment-resistant depressed patients [13] . Our results are in line with the significantly lower platelet 5-HT concentration in medication-free depressed patients compared to healthy controls [23, 24] . The limitation of the present study was that patients were not evaluated with the scales or questionnaires for the presence of depressive symptoms. Our biochemical findings raise a question about the duration of withdrawal of T 4 replacement therapy. Namely, withdrawal of 4 weeks duration might have severe consequences on the medical status of the patients, as it has been shown that total thyroidectomy is associated with higher psychiatric morbidity than partial thyroidectomy [49] . In addition, preclinical studies showed that as early as 7 and 20 days following thyroidectomy neuronal proliferative capacity [50] and synaptic 5-HT levels [51] are reduced. To prevent any possible neuronal damage caused by 4 weeks of severe hypothyreosis [50] , we and others [48] propose a reduction in the duration of T 4 withdrawal from 4 weeks to 3 weeks, and/or a reduction of T 4 replacement dosage to half the usual amount instead of complete withdrawal in patients preparing for scintiscan.
In conclusion, hypothyroid patients had decreased platelet 5-HT concentrations, similar platelet MAO-B activity, higher TSH and lower T 4 levels than healthy euthyroid subjects. There were no significant correlations between biochemical platelet markers and thyroid hormones in hypothyroid patients, suggesting that hypothyroid patients have an altered interaction between the 5-HT system and HPT axis activity, presumably mediated by the reduced 5-HT-induced regulation of HPT axis activity. Our results also indicate that the use of routine peripheral 5-HT measurements (a few times during the hormone withdrawal procedure) might be a diagnostic tool to evaluate depressive symptoms in hypothyroid patients.
